| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.075 | 0.5 |